Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55,482,166
-
Number of holders
-
107
-
Total 13F shares, excl. options
-
27,065,667
-
Shares change
-
+1,903,032
-
Total reported value, excl. options
-
$508,508,214
-
Value change
-
+$36,985,561
-
Put/Call ratio
-
189%
-
Number of buys
-
58
-
Number of sells
-
-42
-
Price
-
$18.79
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q1 2018
121 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q1 2018.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27,065,667 shares
of 55,482,166 outstanding shares and own 49% of the company stock.
Largest 10 shareholders include TRV GP III, LLC (9,391,176 shares), FMR LLC (2,873,992 shares), BB BIOTECH AG (1,992,641 shares), BlackRock Inc. (1,438,029 shares), Casdin Capital, LLC (1,135,000 shares), VANGUARD GROUP INC (947,095 shares), FARALLON CAPITAL MANAGEMENT LLC (890,000 shares), STATE STREET CORP (798,946 shares), EVENTIDE ASSET MANAGEMENT, LLC (703,425 shares), and MILLENNIUM MANAGEMENT LLC (618,021 shares).
This table shows the top 107 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.